» Articles » PMID: 21300778

Parity and Placental Infection Affect Antibody Responses Against Plasmodium Falciparum During Pregnancy

Abstract

Women are at higher risk of Plasmodium falciparum infection when pregnant. The decreasing risk of malaria with subsequent pregnancies is attributed to parity-dependent acquisition of antibodies against placental parasites expressing variant surface antigens, VAR2CSA, that mediate placental sequestration through adhesion to chondroitin sulfate A (CSA). However, modulation of immunity during pregnancy may also contribute to increase the risk of malaria. We compared antibody responses among 30 Mozambican primigravidae and 60 multigravidae at delivery, 40 men, and 40 children. IgG levels were measured against the surface antigens of erythrocytes infected with P. falciparum isolated from 12 pregnant women (4 placental and 8 peripheral blood isolates) and 26 nonpregnant hosts. We also measured IgG levels against merozoite recombinant antigens and total IgG. Placental P. falciparum infection was associated with increased levels of total IgG as well as IgG levels against merozoite antigens and parasite isolates from pregnant and nonpregnant hosts. We therefore stratified comparisons of antibody levels by placental infection. Compared to multigravidae, uninfected primigravidae had lower total IgG as well as lower levels of IgGs against peripheral blood isolates from both pregnant and nonpregnant hosts. These differences were not explained by use of bed nets, season at delivery, neighborhood of residence, or age. Compared to men, infected primigravidae had higher levels of IgGs against isolates from pregnant women and CSA-binding lines but not against other isolates, supporting the concept of a pregnancy-specific development of immunity to these parasite variants. Results of this study show that parity and placental infection can modulate immune responses during pregnancy against malaria parasites.

Citing Articles

IgG and IgM responses to the Plasmodium falciparum asexual stage antigens reflect respectively protection against malaria during pregnancy and infanthood.

Gbaguidi M, Adamou R, Edslev S, Hansen A, Domingo N, Dechavanne C Malar J. 2024; 23(1):154.

PMID: 38764069 PMC: 11103834. DOI: 10.1186/s12936-024-04970-7.


Assessing the relationship between gravidity and placental malaria among pregnant women in a high transmission area in Ghana.

Akinnawo A, Seyram K, Boamah Kaali E, Harrison S, Dosoo D, Cairns M Malar J. 2022; 21(1):240.

PMID: 35987638 PMC: 9392271. DOI: 10.1186/s12936-022-04252-0.


Multiple Plasmodium falciparum drug resistance polymorphisms identified in a pregnant woman with severe malaria and a concomitant spontaneous abortion in Cross River, Nigeria, West Africa.

Oboh M, Faal F, Adeniji O, Correa S, Amawu A, Ogban E Malar J. 2022; 21(1):160.

PMID: 35659662 PMC: 9164396. DOI: 10.1186/s12936-022-04176-9.


Adverse pregnancy outcomes are associated with Plasmodium vivax malaria in a prospective cohort of women from the Brazilian Amazon.

Dombrowski J, Barateiro A, Peixoto E, Barros A, de Souza R, Clark T PLoS Negl Trop Dis. 2021; 15(4):e0009390.

PMID: 33914739 PMC: 8112668. DOI: 10.1371/journal.pntd.0009390.


The Development, Fine Specificity, and Importance of High-Avidity Antibodies to VAR2CSA in Pregnant Cameroonian Women Living in Yaoundé, an Urban City.

Vanda K, Bobbili N, Matsunaga M, Chen J, Salanti A, Leke R Front Immunol. 2021; 12:610108.

PMID: 33717094 PMC: 7953046. DOI: 10.3389/fimmu.2021.610108.


References
1.
Achur R, Valiyaveettil M, Naik R, Ockenhouse C, Zhou A, Megnekou R . Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy. Infect Immun. 2001; 69(12):7487-92. PMC: 98838. DOI: 10.1128/IAI.69.12.7487-7492.2001. View

2.
Watanabe M, Iwatani Y, Kaneda T, Hidaka Y, Mitsuda N, Morimoto Y . Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am J Reprod Immunol. 1997; 37(5):368-77. DOI: 10.1111/j.1600-0897.1997.tb00246.x. View

3.
Keen J, Serghides L, Ayi K, Patel S, Ayisi J, van Eijk A . HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med. 2007; 4(5):e181. PMC: 1880852. DOI: 10.1371/journal.pmed.0040181. View

4.
Oleinikov A, Rossnagle E, Francis S, Mutabingwa T, Fried M, Duffy P . Effects of sex, parity, and sequence variation on seroreactivity to candidate pregnancy malaria vaccine antigens. J Infect Dis. 2007; 196(1):155-64. DOI: 10.1086/518513. View

5.
Avelino M, Campos Jr D, do Carmo Barbosa de Parada J, Castro A . Pregnancy as a risk factor for acute toxoplasmosis seroconversion. Eur J Obstet Gynecol Reprod Biol. 2003; 108(1):19-24. DOI: 10.1016/s0301-2115(02)00353-6. View